Gsk (GSK) Liabilities and Shareholders Equity (2009 - 2026)
Gsk (GSK) posted Liabilities and Shareholders Equity of $82.83 billion for the quarter ended Jun 30, 2026, up 4.8% from $79.05 billion a year earlier but down 2.3% from the prior quarter.
Powered by 
Analysis
Gsk (GSK) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
As of Dec 31, 2025, Gsk's Liabilities and Shareholders Equity came in at $80.58 billion, up 6.0% from the prior year.
- Annual Liabilities and Shareholders Equity shows a five-year compound annual growth rate of -4.8% (years ended Dec 2020 to Dec 2025).
- In prior years, Gsk's Liabilities and Shareholders Equity was $76.01 billion in the year ended Dec 31, 2024 (+3.6%), $73.39 billion in the year ended Dec 31, 2023 (-1.4%), $74.44 billion in the year ended Dec 31, 2022 (-31.6%) and $108.84 billion in the year ended Dec 31, 2021 (+5.4%).
- Quarterly Liabilities and Shareholders Equity has run from a low of $60.41 billion in the quarter ended Mar 31, 2022 to a high of $112.14 billion in the quarter ended Jun 30, 2022 over five years.
- On a year-over-year basis, Liabilities and Shareholders Equity has increased in each of the last seven quarters, with growth averaging 5.6% over the last eight quarters.
- The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was the quarter ended Mar 31, 2023, with growth of 17.9%; the weakest was the quarter ended Mar 31, 2022, with a decline of 43.9%.
- According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $84.76 billion (quarter ended Mar 31, 2026), $81.3 billion (quarter ended Dec 31, 2025) and $82.77 billion (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Gsk | 100.33 Bn | 81.91 Bn | 8.24 Bn | 82.83 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 82.83 Bn |
| Mar 31, 2026 | 84.76 Bn |
| Dec 31, 2025 | 81.30 Bn |
| Sep 30, 2025 | 82.77 Bn |
| Jun 30, 2025 | 79.05 Bn |
| Mar 31, 2025 | 76.46 Bn |
| Dec 31, 2024 | 76.32 Bn |
| Sep 30, 2024 | 75.42 Bn |
| Jun 30, 2024 | 73.29 Bn |
| Mar 31, 2024 | 74.22 Bn |
| Dec 31, 2023 | 73.23 Bn |
| Sep 30, 2023 | 77.09 Bn |
| Jun 30, 2023 | 74.41 Bn |
| Mar 31, 2023 | 71.22 Bn |
| Dec 31, 2022 | 70.55 Bn |
| Sep 30, 2022 | 71.08 Bn |
| Jun 30, 2022 | 112.14 Bn |
| Mar 31, 2022 | 60.41 Bn |
| Dec 31, 2021 | 106.63 Bn |
| Sep 30, 2021 | 108.48 Bn |
API Access
Gsk Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();